Citation Impact
Citing Papers
An engineered 4-1BBL fusion protein with “activity on demand”
2020
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Functional diversity of helper T lymphocytes
1996 StandoutNature
Pro‐ versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic Options
2000
TNF and EPO: major players in the innate immune response: their discovery
2012
Pathogenetic Mechanisms of Septic Shock
1993 Standout
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
2001 Standout
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
1995 Standout
Particulate air pollution and acute health effects
1995 Standout
Elevated Pyrogenic Cytokines in Heatstroke
1993
Prognostic Value of Cytokine Concentrations (Tumor Necrosis Factor–α, Interleukin‐6, and Interleukin‐10) and Clinical Parameters in Severe Melioidosis
2000
Effects of ibuprofen on the physiology and survival of hypothermic sepsis
1999
Persistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS
1995
The Acute Respiratory Distress Syndrome
2000 Standout
New approaches to the treatment of group A streptococcal pharyngitis
2001
Digestion of Streptococcus pneumoniae Cell Walls with Its Major Peptidoglycan Hydrolase Releases Branched Stem Peptides Carrying Proinflammatory Activity
1999
Clinical applications of TNF-α in cancer
1998
Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock
2000
Epidemiology of sepsis: An update
2001
Melioidosis
2003 Standout
Effect of Mechanical Ventilation on Inflammatory Mediators in Patients With Acute Respiratory Distress Syndrome
1999 Standout
CD28 Expression in T Cell Aging and Human Longevity
1998
Heat Stroke
2002 Standout
Sepsis: a roadmap for future research
2015
Severe Sepsis and Septic Shock
2013 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Home treatment of febrile neutropenia: An empirical oral antibiotic regimen
1991
Antibodies to Core Lipopolysaccharide Determinants: Absence of Cross-reactivity with Heterologous Lipopolysaccharides
1991
Interleukin-10-deficient mice develop chronic enterocolitis
1993 Standout
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
2001 StandoutNature
Increased Circulating Soluble Cd14 Is Associated With High Mortality In Gram-Negative Septic Shock
1995
Has the mortality of septic shock changed with time?
1998
Sepsis and septic shock
2018 Standout
Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γ
1998
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
1992 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Regulation of the Acute Phase Response by Cytokines
1993
An analysis of interleukin-8, interleukin-6 and C-Reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients
1998
The Pathophysiology and Treatment of Sepsis
2003 Standout
Signal Transduction by a Death Signal Peptide
2000 StandoutNobel
Adjunctive therapy in sepsis: a critical analysis of the clinical trial programme
1999
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study
1993 Standout
Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin
1991
New perspectives on basic mechanisms in lung disease. 2. Neutrophil traffic in the lungs: role of haemodynamics, cell adhesion, and deformability.
1993
Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: Routes and intermediate signals
1994
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation
2000
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
2009 Standout
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Cancer-related inflammation
2008 StandoutNature
Inflammatory Cytokines in the BAL of Patients With ARDS
1995
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
The Epidemiology of Sepsis in the United States from 1979 through 2000
2003 Standout
Protection from septic shock by neutralization of macrophage migration inhibitory factor
2000
Staphylococcus aureusInfections
1998 Standout
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
2000 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
1993 StandoutNature
The p66shc adaptor protein controls oxidative stress response and life span in mammals
1999 StandoutNature
Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock
2002 Standout
Immunologic and Hemodynamic Effects of “Low-Dose” Hydrocortisone in Septic Shock
2003
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta.
1994
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group
1991
Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis
1994
Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes
1994
Preventing Complications of Central Venous Catheterization
2003 Standout
Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress
1999
Impact of β2 integrin deficiency on mouse natural killer cell development and function
2011 StandoutNobel
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
CLINICAL CORRELATES OF CHRONIC REJECTION IN PEDIATRIC RENAL TRANSPLANTATION
1996
Activation-Induced Cell Death Limits Effector Function of CD4 Tumor-Specific T Cells
2004
IL-6 is essential in TNF-α-induced fever
1998
Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome
2004 Standout
Characterization of Early Cytokine Responses and an Interleukin (IL)-6–dependent Pathway of Endogenous Glucocorticoid Induction during Murine Cytomegalovirus Infection
1997
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection
1997
Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock.
1995
Antiendotoxin activity of cationic peptide antimicrobial agents
1996
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.
1995 StandoutNobel
Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection
1992
Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors
2007 StandoutNobel
Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome
2000 Standout
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
2004 StandoutNobel
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression
1995
Interleukin 10 protects mice from lethal endotoxemia.
1993
The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)
1995 Standout
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis
2002 Standout
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
2013
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
2006 StandoutNobel
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
1999
Works of J. Gérain being referenced
Bacteraemia caused by non-aeruginosa Pseudomonas species in a cancer centre
1992
High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines
1991
Systemic and Hemodynamic Effects of Recombinant Tumor Necrosis Factor Alpha in Isolation Perfusion of the Limbs
1995
Production of tumor necrosis factor-α by naive or memory T lymphocytes activated via CD28
1992
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients
2000
SYSTEMIC RELEASE OF SOLUBLE TNF RECEPTORS AFTER HIGH-DOSE TNF IN ISOLATED LIMB PERFUSION
1997
High serum levels of TNF-α after its administration for isolation perfusion of the limb
1992
Rationale for using TNFα and chemotherapy in regional therapy of melanoma
1994
Rapid increase in plasma tenascin‐C concentration after isolated limb perfusion with high‐dose tumor necrosis factor (TNF), interferon gamma (IFNγ) and melphalan for regionally advanced tumors
1995
Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.
1990
[Prevention using pefloxacin of infections in cancer patients with granulocytopenia].
1989
Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.
1995
Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
1992
[Prevention of bacterial infections using ciprofloxacin in granulocytopenic patients with cancer].
1989